Axa’s Clearfield CLFD Stock Holding History

Axa’s Portfolio CLFD Stock Details CLFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,400	Closed	-$414K	–	1117
2022 Q4	$414K	Hold	4,400	–	–	﹤0.01%	1007
2022 Q3	$460K	Buy	+4,400	New	+$428K	﹤0.01%	979

Other funds holding CLFD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's CLFD Position: Q1 2023 in Review

Axa sold out of Clearfield (CLFD) in Q1 2023, closing a stake of 4,400 shares — an estimated $414K sold.

Axa first reported a position in CLFD in Q3 2022 and held it in 2 quarters. The position peaked at $460K in Q3 2022. 172 funds tracked by Wall St. Rank hold CLFD as of Q1 2023.

Axa reported no remaining Clearfield position as of Q1 2023 after selling out during the quarter.
Axa sold 4,400 Clearfield shares in Q1 2023, an estimated $414K.
Axa first reported a position in Clearfield in Q3 2022 and held it in 2 quarters.
Axa's Clearfield position peaked at $460K in Q3 2022.
172 funds tracked by Wall St. Rank held Clearfield as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.